Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.
Lancet. 2021 Jun 19;397(10292):2361-2371. doi: 10.1016/S0140-6736(21)00592-4. Epub 2021 Jun 4.
Lancet. 2021.
PMID: 34097854
Clinical Trial.
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies.
García-Calderón CB, Sierro-Martínez B, García-Guerrero E, Sanoja-Flores L, Muñoz-García R, Ruiz-Maldonado V, Jimenez-Leon MR, Delgado-Serrano J, Molinos-Quintana Á, Guijarro-Albaladejo B, Carrasco-Brocal I, Lucena JM, García-Lozano JR, Blázquez-Goñi C, Reguera-Ortega JL, González-Escribano MF, Reinoso-Segura M, Briones J, Pérez-Simón JA, Caballero-Velázquez T.
García-Calderón CB, et al. Among authors: reinoso segura m.
Front Immunol. 2023 Apr 14;14:1152498. doi: 10.3389/fimmu.2023.1152498. eCollection 2023.
Front Immunol. 2023.
PMID: 37122702
Free PMC article.
Item in Clipboard
The incidental detection of clonal haemopoiesis of indeterminate potential with del(5q).
Prats-Martín C, Vargas MT, Reinoso-Segura M, Caballero-Velázquez T, Martín-Chacón E, Morales-Camacho RM.
Prats-Martín C, et al. Among authors: reinoso segura m.
Br J Haematol. 2022 Mar;196(6):1287. doi: 10.1111/bjh.18006. Epub 2022 Feb 7.
Br J Haematol. 2022.
PMID: 35302650
No abstract available.
Item in Clipboard
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment.
Reinoso-Segura M, Caballero-Velázquez T, Herrera P, Patriarca F, Fanin R, Bruno B, Einsele H, Nahi H, Granell M, López-Corral L, Reguera JL, García-Cadenas I, Gahrton G, Pérez-Simón JA; European Myeloma Network, the European Society for Blood and Marrow Transplantation, and the Spanish Group of Transplantation.
Reinoso-Segura M, et al.
Transplant Cell Ther. 2022 May;28(5):258.e1-258.e8. doi: 10.1016/j.jtct.2022.01.026. Epub 2022 Feb 4.
Transplant Cell Ther. 2022.
PMID: 35131486
Free article.
Clinical Trial.
Item in Clipboard
Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study.
Caballero-Velázquez T, Pérez-López O, Yeguas Bermejo A, Rodríguez Arbolí E, Colado Varela E, Sempere Talens A, Vidriales MB, Solé-Rodríguez M, Quirós Caso C, Pérez López E, Reinoso Segura M, Prats-Martín C, Montesinos P, Pérez-Simón JA.
Caballero-Velázquez T, et al. Among authors: reinoso segura m.
Cancers (Basel). 2023 Mar 5;15(5):1609. doi: 10.3390/cancers15051609.
Cancers (Basel). 2023.
PMID: 36900400
Free PMC article.
Item in Clipboard
Cite
Cite